Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 45.50M | $ 33.70M | $ 32.70M | $ 22.30M | $ 10.50M |
Total Assets | $ 94.50M | $ 83.50M | $ 80.70M | $ 70.20M | $ 55.10M |
Total Debt | $ 5.00M | $ 5.40M | $ 5.80M | $ 6.20M | $ 6.40M |
Net Debt | $ -40.50M | $ -28.30M | $ -26.90M | $ -16.10M | $ -4.10M |
Total Liabilities | $ 50.50M | $ 48.50M | $ 49.90M | $ 45.40M | $ 42.10M |
Stockholders Equity | $ 44.00M | $ 35.00M | $ 30.80M | $ 24.80M | $ 13.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |